Publications by authors named "Rohit Pal"

Claim this Profile
S
Steroidal Scaffolds as Anticancer Agents: Evolution, FDA Approvals, Synthetic Derivatives, SAR Profiles, and Translational Perspectives.
Prabhugouda Gugal, Hemalatha Kamurthy, Rohit Pal, Gurubasavaraja Swamy P M, Sanjay M

Chem Biodivers· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electron Paramagnetic Resonance Detection of Singlet Oxygen: Opportunities and Pitfalls of Sterically Hindered Amine Trapping Agents.
Chun-Yin Lau, Goutham Rangarajan, Rohit Pal, Ramin Farnood

Chempluschem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzimidazole Derivatives in Breast Cancer: Target-Specific Therapeutic Breakthroughs.
S Mounika, K Hemalatha, Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Pradan P Jain

Curr Top Med Chem· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF inhibitors in Melanoma: Structural Insights, Therapeutic Resistance, and Biological Evaluation of Quinazoline Derivatives.
Arghya Paik, Gurubasavaraja Swamy Purawarga Matada, Abhishek Ghara, Rohit Pal, Gajjala Pavani

Eur J Med Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and Molecular Profiling of Pyrimidine-Furan Derivatives Targeting EGFR, EGFR, and EGFR in NSCLC: In Vitro and In Silico Evaluation.
Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, Md Jawaid Akhtar, Bhupinder Kumar

Chem Biodivers· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panchakarma treatment for painful Post-Traumatic Trigeminal Neuropathy - A case report.
Manoj Shamkuwar, Kiran Nimbalkar, Diwakar Mani Tripathi, Bhavna Bhatia, Manisha, Rohit Pal

J Ayurveda Integr Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In silico design, synthesis of a novel chalcone derivative and its in vitro and in vivo anticancer activity against colon cancer-induced mouse model.
Uday Raj Sharma, Sushavan Roy, Gurubasavaraja Swamy Purawargaar Matada, Manjunatha P M, Suresh Janadri, Rohit Pal

Naunyn Schmiedebergs Arch Pharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Computational and Experimental Insights Into MEK1/2 Inhibitors: Structural Validation, Docking, ADMET, Molecular Dynamics, and Anticancer Evaluation.
Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli

Chem Biodivers· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure-activity relationship.
E Haripriya, K Hemalatha, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, Pronoy Kanti Das

Mol Divers· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation cancer therapeutics: PROTACs and the role of heterocyclic warheads in targeting resistance.
Ebna Azizal Omar, Rajesh R, Pronoy Kanti Das, Rohit Pal, Gurubasavaraja Swamy Purawarga Matada

Eur J Med Chem· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advancements in mechanistic research, therapeutic potential, and structure-activity relationships of aurora kinase inhibitors in cancer therapies.
Ghanshyam Teli, Lalmohan Maji, Rohit Pal, Neelesh Maheshwari, Gurubasavaraja Swamy Purawarga Matada

Bioorg Chem· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current developments in PI3K-based anticancer agents: Designing strategies, biological activity, selectivity, structure-activity correlation, and docking insight.
Md Ashadul Sk, Hemalatha K, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, Manjushree B V

Bioorg Chem· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies.
Aayishamma I, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, Abhishek Ghara, Nimmagadda Venkata Satya Sai Aishwarya

Eur J Med Chem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC).
Rohit Pal, Ghanshyam Teli, Sindhuja Sengupta, Lalmohan Maji, Gurubasavaraja Swamy Purawarga Matada

J Biomol Struct Dyn· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrazole, Pyrazoline, and Fused Pyrazole Derivatives: New Horizons in EGFR-Targeted Anticancer Agents.
Ketan R Hosamani, Hemalatha K, Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Kumaraswamy B

Chem Biodivers· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic potential of anticancer activity of nitrogen-containing heterocyclic scaffolds as Janus kinase (JAK) inhibitor: Biological activity, selectivity, and structure-activity relationship.
Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ghanshyam Teli, Moumita Saha, Rajiv Patel

Bioorg Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An insight into sustainable and green chemistry approaches for the synthesis of quinoline derivatives as anticancer agents.
B Kumaraswamy, K Hemalatha, Rohit Pal, Gurubasavaraja Swamy Purawarga Matada, Ketan R Hosamani

Eur J Med Chem· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
based discovery of potential Keap1 inhibitors using the strategies of pharmacophore screening, molecular docking, and MD simulation studies.
Ekta Singh, Gurubasavaraja Swamy Purawarga Matada, Prasad Sanjay Dhiwar, Rajesh B Patil, Rohit Pal

Bioimpacts· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An updated literature on BRAF inhibitors (2018-2023).
Lalmohan Maji, Ghanshyam Teli, Nulgumnalli Manjunathaiah Raghavendra, Sindhuja Sengupta, Rohit Pal

Mol Divers· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the Occurrence of Substituted and Unsubstituted, Polycyclic Aromatic Compounds in Coking Wastewater Treatment Plant Effluent using Machine Learning Regression.
Rohit Pal, Luke Arcamo, Ramin Farnood

Chemosphere· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship.
Pronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, Lalmohan Maji, Prasad Sanjay Dhiwar

Eur J Med Chem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic product-based approach toward potential antileishmanial drug development.
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, Gurubasavaraja Swamy Purawarga Matada

Eur J Med Chem· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of natural anti-parasitic guided development of synthetic drugs for leishmaniasis.
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, Gurubasavaraja Swamy Purawarga Matada

Eur J Med Chem· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanomedicine-fortified cosmeceutical serums for the mitigation of psoriasis and acne.
Priya Patel, Rohit Pal, Krishna Butani, Sudarshan Singh, Bhupendra G Prajapati

Nanomedicine (Lond)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medicinal Chemistry Perspectives on Recent Advances in Src Kinase Inhibitors as a Potential Target for the Development of Anticancer Agents: Biological Profile, Selectivity, Structure-Activity Relationship.
Ghanshyam Teli, Rohit Pal, Lalmohan Maji, Sindhuja Sengupta, Nulgumnalli Manjunathaiah Raghavendra

Chem Biodivers· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis